Cor, ThromboSys Inc. deal

The companies entered into a three-year agreement to discover drugs based on research in integrin signal transduction. Integrins are a family of cell-surface adhesion receptors that have been implicated in severe cardiovascular diseases, among other conditions. The companies will seek to elucidate the signaling pathways by which integrins affect cellular function and to identify therapeutic agents that target these pathways. ...